TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$115 Million

Twist Bioscience Corporation

Follow-on Offering

Bookrunner, June 2020

Twist Bioscience Corporation

Twist is a synthetic biology company that has developed a DNA synthesis platform to industrialize the engineering of biology.  Twist utilizes proprietary technology to manufacture synthetic DNA by “writing” DNA onto a silicon chip.   Twist has combined this technology with proprietary software, scalable commercial infrastructure, and an e-commerce platform to create an integrated technology platform that allows it to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sample preparation, and antibody libraries for drug discovery and development.